Sildenafil Citrate

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
84
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Impotence

Conditions

Impotence, Hypertension

Trial Timeline

Mar 1, 2005 โ†’ Nov 1, 2005

About Sildenafil Citrate

Sildenafil Citrate is a approved stage product being developed by Pfizer for Impotence. The current trial status is completed. This product is registered under clinical trial identifier NCT00150358. Target conditions include Impotence, Hypertension.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (14)

NCT IDPhaseStatus
NCT00878943Pre-clinicalCompleted
NCT03356353Phase 3UNKNOWN
NCT01365585Pre-clinicalCompleted
NCT00772135Pre-clinicalUNKNOWN
NCT00517933Phase 3Completed
NCT00468650ApprovedCompleted
NCT00245258ApprovedCompleted
NCT00159900ApprovedCompleted
NCT00150358ApprovedCompleted
NCT00151463ApprovedCompleted
NCT00141310Phase 2Terminated
NCT00317421Phase 2Completed
NCT00159861Phase 3Completed
NCT00159887Phase 3Completed

Competing Products

20 competing products in Impotence

See all competitors
ProductCompanyStageHype Score
tadalafilEli LillyApproved
85
tadalafil + sildenafilEli LillyApproved
85
tadalafil + placebo + tadalafil + tadalafil + tadalafil + placeboEli LillyPhase 3
77
GPI 1485EisaiPhase 2
52
tadalafil + sildenafilEli LillyApproved
85
tadalafilEli LillyApproved
85
tadalafil + sildenafilEli LillyPhase 3
77
tadalafilEli LillyPhase 3
77
tadalafil + placebo + tadalafil + tadalafilEli LillyPhase 3
77
tadalafil + PlaceboEli LillyPhase 3
77
tadalafil + tadalafil + placeboEli LillyPhase 3
77
tadalafil + tadalafil + placeboEli LillyPhase 3
77
Fluvastatin-sodiumNovartisPhase 3
77
UK0369,003 + Cialis (Tadalafil)PfizerPhase 2
51
Viagra (Sildenafil citrate)PfizerApproved
84
sildenafil citratePfizerApproved
84
Placebo + Viagra (sildenafil citrate)PfizerApproved
84
UK-369,003PfizerPhase 2
51
Viagra (Sildenafil Citrate) 100 mgPfizerApproved
84
Viagra (Sildenafil citrate)PfizerApproved
84